Search companies

Live

Tuesday, 17 November 2026 · 580 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

Xenitra Highlights Pharmaceutical and Web3 Growth Plans After September-Quarter Sales

Xenitra Limited (XEN) · Consumer discretionary

XEN: $0.002 +0.00% · MC: $14M

Xenitra’s November investor presentation outlines plans to expand its pharmaceutical and Web3 commerce businesses, following September-quarter pharmaceutical sales of approximately $864,000 and more than $2 million in Web3 sales since April, as reported in its recent quarterly update. The presentation describes pharmaceutical margin potential of 20% to 40% and Web3 margins of 40% to 90%; these are stated profiles, not reported realised margins.

Source announcements: 2026-11-06 11:58 to 2026-11-06 11:58 Sydney time
Story updated 2026-11-06 12:01 Sydney time
SourcesInvestor Presentation - November 2026
Comments